In a murine NEC model, addition of the neutral HMO 2′-fucosyllactose (2′-FL) to formula feeding reduced intestinal gene expression of IL6, IL1β and TLR4 [91]. The gene discussed is IL6; the disease is necrotizing enterocolitis.